Fig. 4.

Convergent future of stored RBC assessment toward precision transfusion. Novel -omics and ML technologies have recently been used to assess RBC storage lesions. We envision that the integration of these technologies will identify key quality metrics (quality indices) for stored RBCs in the near future. These quality indices can then guide LOC platforms armed with novel biosensors to continuously monitor stored RBC quality and then match the properties of the RBC unit to the needs of the patient.